‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Breast CancerMetastatic Breast Cancer
TILs and PET-CT can predict pCR in HER2-positive metastatic breast cancerJune 2, 2020Breast CancerMetastatic Breast Cancer
Treating primary tumor doesn’t improve OS in stage IV breast cancerJune 1, 2020Breast CancerMetastatic Breast Cancer
Pyrotinib bests lapatinib in HER2+ metastatic breast cancerMay 31, 2020Breast CancerMetastatic Breast Cancer
Expanding the role of PARP inhibitors in breast cancerMay 31, 2020Breast CancerMetastatic Breast Cancer
ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancerMay 31, 2020Breast Cancer
Tucatinib improves PFS, OS in HER2+ breast cancer with brain metastasesMay 30, 2020Breast CancerMetastatic Breast Cancer
TRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancerMay 30, 2020Breast Cancer
Pembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancerMay 29, 2020Breast CancerMetastatic Breast Cancer
